StonvexLoading…
StonvexStonvexStonvexCore line items from NRC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $34.80M | $137.39M | $102.20M | $67.59M |
Operating Income | $5.57M | $22.59M | $17.92M | $10.18M |
Net Income | $3.22M | $11.60M | $9.80M | $-106.00K |
EPS (Diluted) | $0.14 | $50.00 | $0.43 | $0.25 |
Total Assets | $134.56M | $134.88M | $135.72M | $141.39M |
Total Liabilities | $121.06M | $120.89M | $121.41M | $120.06M |
Cash & Equivalents | $2.55M | $4.14M | $2.22M | $5.27M |
Free Cash Flow OCF − CapEx | $5.35M | $15.74M | $9.69M | $-489.00K |
Shares Outstanding | 22.54M | 22.64M | 22.66M | 23.10M |